THE RISK OF THERAPY-RELATED MYELODYSPLASIA ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY. Mediterr J Hematol Infect Dis 2012, 4 (1), e2012022. https://doi.org/10.4084/mjhid.2012.022.